NEW YORK (GenomeWeb News) – Martinsried, Germany-based Kinaxo Biotechnologies today said that it has inked sales and marketing pacts in the US and Japan for its Cellular Target Profiling service.
 
In the US, New York-based BioCatalyst International will support the introduction of the service, while UK-based BioFocus DPI will provide similar support in Japan.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.